Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ojeda

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Seminars in Oncology|March 4, 2000
Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: preliminary results of a phase II trialR Colomer, A Llombart, A Lluch, et al.
Revista Clinica Espanola|February 1, 1995
[Intensive chemotherapy with support of peripheral hematopoietic progenitor cells, mobilized with high-dose cyclophosphamide and G-CSF: fast hematologic recovery]C Sola, L Mendoza, B Amill, et al.
Bone Marrow Transplantation|June 1, 2002
The role of granulocyte colony-stimulating factor (G-CSF) in the post-transplant periodJ Hornedo, C Solá, C Solano, et al.
Medicina Clinica|February 11, 1995
[10 Year follow up of chemotherapy and surgery on the second laparotomy in advanced ovarian cancer]B Ojeda, M Llanos, J Brunet, et al.
Breast Cancer Research and Treatment|April 1, 1995
A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancerM C Alonso, J M Tabernero, B Ojeda, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|June 19, 2021
Socio-academic Factors Influencing Knowledge About Organ Donation among Medical Students in Paraguay, 2018T R Aveiro-Róbalo, X Paredes-González, C Recalde-Hellman, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 19, 2021
Soluble guanylate cyclase stimulation in late gestation does not mitigate asymmetric intrauterine growth restriction or cardiovascular risk induced by placental ischemia in the ratLaura E Coats, Bhavisha A Bakrania, Daniel R Bamrick-Fernandez, et al.
Seminars in Oncology|November 5, 1997
Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian CancerA Cervantes, C Mendiola, J M del Campo, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 11, 2020
Stimulation of soluble guanylate cyclase diminishes intrauterine growth restriction in a rat model of placental ischemiaLaura E Coats, Daniel R Bamrick-Fernandez, Allison M Ariatti, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 16, 2006
Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domainR Colomer, A Llombart-Cussac, I Tusquets, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Seminars in Oncology|March 4, 2000
Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: preliminary results of a phase II trialR Colomer, A Llombart, A Lluch, et al.
Revista Clinica Espanola|February 1, 1995
[Intensive chemotherapy with support of peripheral hematopoietic progenitor cells, mobilized with high-dose cyclophosphamide and G-CSF: fast hematologic recovery]C Sola, L Mendoza, B Amill, et al.
Bone Marrow Transplantation|June 1, 2002
The role of granulocyte colony-stimulating factor (G-CSF) in the post-transplant periodJ Hornedo, C Solá, C Solano, et al.
Medicina Clinica|February 11, 1995
[10 Year follow up of chemotherapy and surgery on the second laparotomy in advanced ovarian cancer]B Ojeda, M Llanos, J Brunet, et al.
Breast Cancer Research and Treatment|April 1, 1995
A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancerM C Alonso, J M Tabernero, B Ojeda, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|June 19, 2021
Socio-academic Factors Influencing Knowledge About Organ Donation among Medical Students in Paraguay, 2018T R Aveiro-Róbalo, X Paredes-González, C Recalde-Hellman, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 19, 2021
Soluble guanylate cyclase stimulation in late gestation does not mitigate asymmetric intrauterine growth restriction or cardiovascular risk induced by placental ischemia in the ratLaura E Coats, Bhavisha A Bakrania, Daniel R Bamrick-Fernandez, et al.
Seminars in Oncology|November 5, 1997
Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian CancerA Cervantes, C Mendiola, J M del Campo, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 11, 2020
Stimulation of soluble guanylate cyclase diminishes intrauterine growth restriction in a rat model of placental ischemiaLaura E Coats, Daniel R Bamrick-Fernandez, Allison M Ariatti, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 16, 2006
Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domainR Colomer, A Llombart-Cussac, I Tusquets, et al.
Pageof 10